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ABSTRACT
Distal embolization is an acute complication of percutaneous coronary intervention (PCI). Distal embolization of
plaque and thrombus material is considered as a major cause of insufficient reperfusion despite a fully patent infarct-
related artery, apart from ischemic microvascular damage and reperfusion-induced regional inflammatory responses.
In a recent study, angiographic evidence of distal embolization was associated with an 8-fold increase in 5-year
mortality. We reported on our experience with distal embolization durante PCI which lead the patient developed ST-
Elevation Myocardial Infarct (STEMI) inferior and posterior accompanied with severe chest pain and was treated in
the Intesive Coronary Care Unit (ICCU). Distal embolization is the case that we should be put into our awareness
because it can worse the after procedural outcome.
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INTRODUCTION
Distal embolization is defined as an abrupt cut-
off in the main vessel or one of the coronary
branches of the infarct-related artery, distal to the
angioplasty site.1Downstream embolization can be
in the form of thrombus and/or plaque contents
(atheroma) with vascular obstruction is common
after PCI.2 Angiographic evidence of distal
embolization is found in 9% to 15% of the patients
after primary PCI for acute myocardial infarction,
but the true incidence of distal embolization may be
considerably higher, as suggested by autopsy studies
and experience with distal protection devices. Distal
embolization appears to have major impact on long-
term clinical outcome after primary PCI.3
Myocardial ischemia can result from any
of the coronary artery complications and can lead
to variety of complications either during or after
PCI, including chest pain, ST elevation myocardial
infact (STEMI), cardiac enzyme elevation, and
myocardial stunning.2We reported on our experience
with distal embolization durante PCI which lead the
patient developed STEMI inferior and posterior.
CASE REPORT
A 51 year-old male with diabetes, hypertension
and hypercholesterolemia presented with non-ST-
elevation myocardial infarction (NSTEMI). His
coronary angiogram showed 90% stenosis in mid-
and 80% stenosis in distal part of right coronary
artery (RCA) and 40% left anterior descendent
(LAD) artery (FIGURE 1).
The PCI procedure revealed, 80% stenosis in
distal part of right coronary artery (RCA) was dilated
with Voyager 30/15 ballon (FIGURE 2) and 90%
stenosis in mid of part of RCA treated direct stent
with Coroflex Please 4.0/16 but unsuccessful,
showed an acute closure in distal part of RCA
(FIGURE 3 and 4).
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FIGURE 1. 80% and 90% stenosis in RCA FIGURE 2. Predilatation RCA distal
FIGURE 3. Direct stent RCA mid FIGURE 4. Acute clossure
The lesion was dilatated by voyager 30/15
balloon and showed TIMI-2 (Thrombolysis in
Myocardial Infarction trial)-2 flow (FIGURE 5).
After predilatation, Tsunami Gold 4.0/20 stent was
deployed across the lesion. The angiogram showed
0 percent residual but still had TIMI-2 flow because
there was a distal embolization (FIGURE 6).
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FIGURE 5. Distal embolization in bifucartion FIGURE 6. Final result TIMI-2 flow after stent deployed
The patient suffered typical chest pain after
PCI with the electrocardiogram (ECG) showed
STEMI inferior and posterior. The cardiac enzymes
were elevated, glutamic oxaloacetic transaminase
(GOT) from 24 u/L to 471 u/L, lactate dehydro-
genase 1788 u/L, creatine kinase – MB isoform
(CK-MB) 237.1 u/L, and troponin I more than 22.78
ng/mL. The patient was treated in ICCU with
tirofiban (Aggrastat®) 0.15mcg/kg/hour continued
with unfractionated heparin (UFH), acetylsalicylic
acid 160 mg twice a day, clopidogrel 75 mg once a
day, isosorbide dinitrate 5mg three times a day,
atorvastatine 10mg once a day, amlodipine 5mg once
a day, fenofibrate 200 mg once a day, ramipril 5mg
once a day, and sliding scale to control blood sugar.
The third day in ICCU, patient suffered severe
chest pain followed with bradycardia. The patient
was treated with cervical epidural block combination
chirocaine 0.125 mg and morfine 0.125 mg every
eight hour. The patient had no chest pain in ninth
day and allowed to discharge from hospital.
DISCUSSION
Percutaneous transluminal coronary angioplasty
(PTCA) was associated with two major limitations:
acute (during the procedure) or subacute (after the
procedure and within 30 days) vessel closure; and
late (four to eight months postprocedure)
thrombosis. The availability of intracoronary stents
(PCI) and the ongoing improvements in stent design,
technique, and antithrombotic therapy have resulted
in significant reductions in both of these
complications.Acute closure has been reduced from
2 to 10 % with PTCA alone to <1 % in the stent
era. The rate of subacute thrombosis has fallen from
5 % with PTCA alone to about 0.5 to 1.0 % with
stents. Restenosis rates have fallen from 30 to 40
% after balloon angioplasty to 20 to 30 % after bare
metal stents to less than 10 % with drug-eluting
stents.4 Complications associated with PCI are
similar to those resulting from diagnostic cardiac
catheterization, but their prevalence is more
frequent. Complications have been categorized as
major (death, myocardial infarct (MI), and stroke)
or minor (transient ischemic attack, access site
complications, renal insufficiency, or adverse
reactions to radiographic contrast). Additional
specific complications include intracoronary
thrombosis, coronary perforation, tamponade, and
arrhythmias.5
Distal embolism of thrombus and plaque debris
caused by percutaneous coronary intervention (PCI)
has been regarded as a cause of microcirculation
impairment. Distal embolization of plaque debris was
detected more frequently in patients with ruptured
plaque. Microcirculation damage and left ventricular
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dysfunction are increased mainly by distal
embolization of plaque debris rather than of
thrombus.6
Distal embolization can contribute to the “no-
reflow” phenomenon after PCI. No-reflow is thought
to reflect microvascular dysfunction since there is
evidence of myocardial ischemia and reduced
antegrade coronary flow in the absence of epicardial
stenosis or loss of a distal branch. In a report of
patients undergoing PCI for a Non-ST-Elevation
Myocardial Infarct (NSTEMI), those with a
postprocedural troponin I elevation were significantly
more likely to have reduced tissue-level perfusion
than those without a troponin I elevation.2
Anatomical (or angiographic) success after
PCI is defined as the attainment of residual diameter
stenosis less than 50 %, which is generally associated
with at least 20 % improvement in diameter stenosis
and relief of ischemia. With the widespread use of
coronary stent, the angiographic criterion for success
is 20 % stenosis or less when stent is used.
Procedural success is defined as angiographic
success without the occurrence of major
complications (death, MI or coronary artery bypass
graft (CABG) surgery) within 30 days of the
procedure. Clinical success is defined as procedural
success without the need for urgent repeat PCI or
surgical revascularization within the first 30 days of
the procedure.7
Procedural success (TIMI 3 flow) and perfusion
(blush score) were reduced with distal embolization
and associated with larger infark size, lower ejection
fraction, and substantially higher 5-year mortality.8
No-reflow is likely caused by distal embolization of
atheromatous and thrombotic debris dislodged by
balloon inflation or stent implantation. No-reflow is
defined as reduced anterograde perfusion in the
absence of flow-limitation stenosis, and occurs in
up to 2 to 3 % of PCI procedure.7
The diabetic patients tend to have more distal
embolization compare with nondiabetic patients and
it is associated with a significantly higher mortality.
Review study on 1662 patients undergoing primary
angioplasty for STEMI included in 11 randomized
trials. Diabetes was observed in a total of 281
patients (16.9%). Diabetic patients were older, with
a larger prevalence of female gender, hypertension,
hypercholesterolemia, advanced killip class at
presentation and multivessel disease. Diabetes was
associated with significant impaired postprocedural
TIMI-3 flow, myocardial blush grade (MBG) 2-3,
complete ST-segment resolution and more distal
embolization. The association with impaired MBG
and distal embolization was confirmed after
correction for baseline confounding factors. This
study showed that, among patients with STEMI
undergoing primary angioplasty on the top of
glycoprotein IIb-IIIa inhibitors, diabetes mellitus was
independently associated with impaired perfusion
and distal embolization, that contribute to explain
the higher mortality observed in these patients.1
Diabetes is the risk factors for a final TIMI
flow grade 2 after primary PCI. The other risk
factors are age 70 years, longer time to
reperfusion, initial TIMI flow grade d” 1, left
ventricular ejection fraction <50 percent.9 Patient
who do not achieve TIMI 3 (normal) flow after
primary PCI have worse outcomes. The Primary
Angioplasty in Myocardial Infarction (PAMI) trials
reported patients who had a final TIMI flow grade
2 after PCI had significantly higher rates of in-
hospital mortality, and in-hospital major adverse
cardiac events than those with TIMI 3 flow. At one
year, significant differences persisted for mortality,
major adverse cardiac events, and reinfarction.9
CONCLUSION
A case of distal embolization durante PCI has
been reported. The direct stenting failed and showed
acute closure and distal embolization. The patient
suffered severe chest pain and the ECG showed
ST-elevation MI inferior and posterior. Distal
embolization is an acute complication in PCI. We
have to be aware of the possibility thrombus and/or
plaque debris embolization. Study about distal
protection device and intracoronary antithrombotic
to prevent distal embolization are stil ongoing.
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